Resistive Breathing Versus Inspiratory Hold Technique in Patients With Chronic Bronchitis

Chronic Bronchitis Clinical Trial

Official title:

Comparison of Resistive Breathing Versus Inspiratory Hold Technique in Patients With Chronic Bronchitis

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05533931
• Other study ID #: RiphahB Muhammad Makhdoom
• Status: Not yet recruiting
• Phase: N/A
• Start date: September 2022
• Est. completion date: September 2022

Study information

• Verified date: September 2022
• Source: Riphah International University
• Contact: Ghazal Jamshaid, MS CPPT
• Phone: 03040404851
• Email: ghazaljamshaid141[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the study is to determine the importance and impact of resistive breathing techniques versus inspiratory hold techniques in patients with chronic bronchitis and specially to find out if there are any changes seen in results measured via the incentive spirometer.

Description:

Chronic Bronchitis (CB) is defined as a chronic cough and sputum production for at least 3 months a year for 2 consecutive years. It is covered under the umbrella term of Chronic Obstructive Pulmonary Disease (COPD). Chronic bronchitis is thought to be caused by overproduction and hypersecretion of mucus by goblet cells. Epithelial cells lining the airway response to toxic, infectious stimuli by releasing inflammatory mediators and e.g. pro-inflammatory cytokines. During an acute exacerbation of chronic bronchitis, the bronchial mucous membrane becomes hyperemic and edematous with diminished bronchial mucociliary function. This, in turn, leads to airflow impediment because of

luminal obstruction to small airways. The airways become clogged by debris and this further increases the irritation. The characteristic cough of bronchitis is caused by the copious secretion of mucus in chronic bronchitis. Pseudostratified epithelium, highlighting the pseudostratified epithelial cells, goblets cells (shown in blue), then underlying connective tissue.(3) To determine the importance and impact of resistive breathing techniques versus inspiratory hold techniques in patients with chronic bronchitis and specially to find out if there are any changes seen in results measured via incentive spirometer. There are few studies done over it whereas purpose of this research work is to compare these techniques to get better results.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 26
• Est. completion date: September 2022
• Est. primary completion date: September 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 45 Years to 60 Years

Eligibility

Inclusion Criteria:

• • Diagnosed with chronic bronchitis

• Clinically stable patients.

• Both genders.

• Age 45 to 60 years.

• Pink puffers included in this study

• Clients that are involved in research are not allowed for other interventional therapies. They can take their regular medications.

• Patients diagnosed at least 2 years ago with bronchitis.

Exclusion Criteria:

• • Presence of any genetic disorders (cystic fibrosis).

• Recent spinal / chest surgery

• Cardiac issues

• Fractures of vertebra caused by osteoporosis.

Related Conditions & MeSH terms

• Acute Disease
• Bronchitis
• Bronchitis, Chronic
• Chronic Bronchitis
• Respiratory Aspiration

Intervention

Other:
• Resistive Breathing Training group
The patients performed two sessions each of 15 minutes session of resistive breathing for four days a week for six weeks using an inspiratory resistive device. Ask patient to take long slow inspirations while breathing through the resistive device
• inspiratory hold technique
With the patient in a comfortable position such as side lying or reclined, the therapist may assist the patient by placing both hands on abdominal area to provide proprioceptive feedback. Then in a relaxed tone of voice therapist instructs the patient to sniff quickly through the nose three times with slow, relaxed exhalations

Locations

Country	Name	City	State
Pakistan	Mayo hospital	Lahore	Punjab

Sponsors (1)

Lead Sponsor	Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

References & Publications (5)

Andelid K, Öst K, Andersson A, Mohamed E, Jevnikar Z, Vanfleteren LEGW, Göransson M. Lung macrophages drive mucus production and steroid-resistant inflammation in chronic bronchitis. Respir Res. 2021 Jun 7;22(1):172. doi: 10.1186/s12931-021-01762-4. — View Citation

Belman MJ, Thomas SG, Lewis MI. Resistive breathing training in patients with chronic obstructive pulmonary disease. Chest. 1986 Nov;90(5):662-9. — View Citation

Kim HK, Alhammouri MT, Mokhtar YM, Pinsky MR. Estimating left ventricular contractility using inspiratory-hold maneuvers. Intensive Care Med. 2007 Jan;33(1):181-9. Epub 2006 Nov 14. — View Citation

Samaha E, Vierlinger K, Weinhappel W, Godnic-Cvar J, Nöhammer C, Koczan D, Thiesen HJ, Yanai H, Fraifeld VE, Ziesche R. Expression Profiling Suggests Loss of Surface Integrity and Failure of Regenerative Repair as Major Driving Forces for Chronic Obstructive Pulmonary Disease Progression. Am J Respir Cell Mol Biol. 2021 Apr;64(4):441-452. doi: 10.1165/rcmb.2020-0270OC. — View Citation

Wang G, Hallberg J, Um Bergström P, Janson C, Pershagen G, Gruzieva O, van Hage M, Georgelis A, Bergström A, Kull I, Lindén A, Melén E. Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE. Eur Respir J. 2021 Mar 4;57(3). pii: 2002120. doi: 10.1183/13993003.02120-2020. Print 2021 Mar. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	oxygen saturation	amount of oxygen traveling through your body with your red blood cells. Changes will be assessed at baseline, 3rd week and 6th weeks measured	Changes will be assessed at baseline, 3rd week and 6th weeks measured
Primary	Forced expiratory volume in one second	amount of air expired in first one second. Changes will be assessed at baseline, 3rd week and 6th weeks measured	Changes will be assessed at baseline, 3rd week and 6th weeks measured
Primary	Forced vital capacity	the total amount of air exhaled during the FEV test. Changes will be assessed at baseline, 3rd week and 6th weeks measured	Changes will be assessed at baseline, 3rd week and 6th weeks measured
Primary	FEV1/FVC ratio	the amount of air exhaled in the first second divided by all of the air exhaled during a maximal exhalation.	6 weeks
Primary	shortness of breath measured through borge scale of dyspnea	shortness of breath. Changes will be assessed at baseline, 3rd week and 6th weeks measured	Changes will be assessed at baseline, 3rd week and 6th weeks measured
Primary	SGRQ questionnaire	how breathing problems effects quality of life . Changes will be assessed at baseline, 3rd week and 6th weeks measured	Changes will be assessed at baseline, 3rd week and 6th weeks measured